Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

The cost-effectiveness of direct-to-consumer advertising for prescription drugs.

Atherly A, Rubin PH.

Med Care Res Rev. 2009 Dec;66(6):639-57. doi: 10.1177/1077558709335362. Epub 2009 May 7. Review.

PMID:
19423875
2.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

3.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
4.

Does direct-to-consumer advertising affect patients' choice of pain medications?

Liu Y, Doucette WR.

Curr Pain Headache Rep. 2008 Apr;12(2):89-93. Review.

PMID:
18474186
5.

Benefits and harms of direct to consumer advertising: a systematic review.

Gilbody S, Wilson P, Watt I.

Qual Saf Health Care. 2005 Aug;14(4):246-50. Review.

6.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

7.

Direct to consumer advertising in healthcare: history, benefits, and concerns.

Adeoye S, Bozic KJ.

Clin Orthop Relat Res. 2007 Apr;457:96-104. Review.

PMID:
17310934
8.
9.

Advertising of prescription-only medicines to the public: does evidence of benefit counterbalance harm?

Mintzes B.

Annu Rev Public Health. 2012 Apr;33:259-77. doi: 10.1146/annurev-publhealth-031811-124540. Review.

PMID:
22429162
10.

Drug policy: making effective drugs available without bankrupting the healthcare system.

Laupacis A, Anderson G, O'Brien B.

Healthc Pap. 2002;3(1):12-30. Review.

PMID:
12811107
11.

Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.

Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J.

Health Technol Assess. 2001;5(26):1-149. Review.

12.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
13.

The role of marketing in pharmaceutical research and development.

Calfee JE.

Pharmacoeconomics. 2002;20 Suppl 3:77-85. Review.

PMID:
12457428
14.

Patient autonomy and the regulation of direct-to-consumer advertising.

Zachry WM 3rd, Ginsburg DB.

Clin Ther. 2001 Dec;23(12):2024-37; discussion 2022-3. Review.

PMID:
11813936
15.

The impact of direct-to-consumer advertised drugs on drug sales in the US and New Zealand.

Norey E, Simone TM, Mousa SA.

Appl Health Econ Health Policy. 2008;6(2-3):93-102. doi: 10.2165/00148365-200806020-00002. Review.

PMID:
19231903
16.

Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation.

Dündar Y, Boland A, Strobl J, Dodd S, Haycox A, Bagust A, Bogg J, Dickson R, Walley T.

Health Technol Assess. 2004 Jun;8(24):iii-x, 1-125. Review.

17.

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.

Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I.

Health Technol Assess. 2006 Apr;10(11):1-110. Review.

18.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

19.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

20.

Direct-to-consumer advertising of prescription medication in New Zealand.

Every-Palmer S, Duggal R, Menkes DB.

N Z Med J. 2014 Aug 29;127(1401):102-10. Review.

PMID:
25225761
Items per page

Supplemental Content

Write to the Help Desk